Elequin Capital’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-1
Closed -$9 – 624
2024
Q3
$9 Buy
+1
New +$8 ﹤0.01% 376
2024
Q2
– Sell
-4
Closed -$60 – 347
2024
Q1
$60 Buy
+4
New +$73 ﹤0.01% 232
2023
Q3
– Sell
-50
Closed -$1.27K – 599
2023
Q2
$1.27K Buy
+50
New +$1.26K ﹤0.01% 469
2022
Q4
– Sell
-92
Closed -$2K – 724
2022
Q3
$2K Sell
92
-143
-61% -$5.02K ﹤0.01% 486
2022
Q2
$8K Buy
235
+6
+3% +$255 ﹤0.01% 259
2022
Q1
$17K Buy
+229
New +$16.5K ﹤0.01% 134

Other funds holding TDOC

Elequin Capital's TDOC Position: Q4 2024 in Review

Elequin Capital sold out of Teladoc Health (TDOC) in Q4 2024, closing a stake of 1 share — an estimated $9 sold.

Elequin Capital first reported a position in TDOC in Q1 2022 and held it in 6 quarters. The position peaked at $17K in Q1 2022. 381 funds tracked by Wall St. Rank hold TDOC as of Q4 2024.

  • Elequin Capital reported no remaining Teladoc Health position as of Q4 2024 after selling out during the quarter.
  • Elequin Capital sold 1 Teladoc Health share in Q4 2024, an estimated $9.
  • Elequin Capital first reported a position in Teladoc Health in Q1 2022 and held it in 6 quarters.
  • Elequin Capital's Teladoc Health position peaked at $17K in Q1 2022.
  • 381 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2024.

Based on Elequin Capital's 13F filing for Q4 2024, filed 18 Feb 2025.